A systematic review reveals that GLP-1 receptor agonists may help reduce certain substance use disorders, but findings are inconsistent due to study variability and patient differences.
With sweeping NIH reform on the table, GOP previews new era of research scrutiny
WASHINGTON — There seems to be broad agreement that change is coming for the National Institutes of Health. It is just a matter of how
June 18, 2024